Drug Type Antibody fusion proteins |
Synonyms Anti-fap/interleukin-2 fusion protein ro6874281, Simlukafusp alfa + [5] |
Target |
Mechanism FAP modulators(Fibroblast activation protein alpha modulators), IL-2Rβγ agonists(Interleukin-2 Rβγ agonists), Immunomodulators |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Uterine Cervical Cancer | Phase 2 | GB | 19 Feb 2018 | |
Uterine Cervical Cancer | Phase 2 | CH | 19 Feb 2018 | |
Uterine Cervical Cancer | Phase 2 | TW | 19 Feb 2018 | |
Uterine Cervical Cancer | Phase 2 | IL | 19 Feb 2018 | |
Uterine Cervical Cancer | Phase 2 | TR | 19 Feb 2018 | |
Metastatic Pancreatic Ductal Adenocarcinoma | Phase 2 | ES | 05 Jul 2017 | |
Metastatic Pancreatic Ductal Adenocarcinoma | Phase 2 | US | 05 Jul 2017 | |
Metastatic Pancreatic Ductal Adenocarcinoma | Phase 2 | KR | 05 Jul 2017 | |
Metastatic Pancreatic Ductal Adenocarcinoma | Phase 2 | DE | 05 Jul 2017 | |
Metastatic Pancreatic Ductal Adenocarcinoma | Phase 2 | JP | 05 Jul 2017 |
Phase 2 | 34 | (hzszlzdqjj) = lqunxzgvtb tkovgaxuua (xolrhlgunl, 10.4 - 36.8) View more | Positive | 06 May 2024 | |||
Phase 1 | Squamous Cell Carcinoma of Head and Neck Second line | 46 | (gouvnytrcw) = mfvyhsendn nvgxrbspzg (bsejxuzsbt ) View more | Negative | 16 Sep 2021 | ||
NCT03063762 (ASCO2021) Manual | Phase 1 | 69 | (Arm A) | (rsozlgtdct) = hukqnojead jtpqouiixe (qzposglnlh, 12.95 - 40.12) View more | Positive | 20 May 2021 | |
(Arm B) | (rsozlgtdct) = qpxibvhnde jtpqouiixe (qzposglnlh, 27.67 - 66.68) | ||||||
Phase 1/2 | - | (ohojjlhszk) = ukkirjozou lnjnpbqgqp (dmbvexdseo, 1.4 - 2.7) | Negative | 08 Jul 2020 | |||
(uzurzdzzum) = wuegbpejkl omywgtbiee (lihgrqmyld ) View more | |||||||
NCT02627274 (ESMO2018) Manual | Phase 1 | 16 | (msvmzzlruv) = mild or moderate sjrfwvwdhj (sgjzoydynk ) View more | Positive | 20 Oct 2018 |